Oppenheimer & Co’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.63M | Sell |
3,012
-78
| -3% | -$40.3K | 0.02% | 707 |
|
|
2026
Q2 | $1.67M | Buy |
3,090
+17
| +0.6% | +$9.6K | 0.02% | 718 |
|
|
2026
Q1 | $1.82M | Sell |
3,073
-123
| -4% | -$61.3K | 0.02% | 624 |
|
|
2025
Q4 | $1.56M | Sell |
3,196
-1,098
| -26% | -$511K | 0.02% | 620 |
|
|
2025
Q3 | $1.8M | Sell |
4,294
-502
| -10% | -$169K | 0.02% | 647 |
|
|
2025
Q2 | $1.38M | Buy |
4,796
+308
| +7% | +$92K | 0.02% | 712 |
|
|
2025
Q1 | $1.38M | Sell |
4,488
-179
| -4% | -$61.3K | 0.02% | 667 |
|
|
2024
Q4 | $1.65M | Sell |
4,667
-1,581
| -25% | -$581K | 0.02% | 601 |
|
|
2024
Q3 | $2.24M | Buy |
6,248
+1,078
| +21% | +$364K | 0.03% | 513 |
|
|
2024
Q2 | $1.65M | Buy |
5,170
+530
| +11% | +$140K | 0.03% | 595 |
|
|
2024
Q1 | $1.07M | Buy |
4,640
+699
| +18% | +$158K | 0.02% | 719 |
|
|
2023
Q4 | $867K | Buy |
3,941
+505
| +15% | +$116K | 0.02% | 756 |
|
|
2023
Q3 | $776K | Sell |
3,436
-3,850
| -53% | -$887K | 0.02% | 763 |
|
|
2023
Q2 | $1.61M | Buy |
7,286
+722
| +11% | +$160K | 0.03% | 533 |
|
|
2023
Q1 | $1.47M | Sell |
6,564
-659
| -9% | -$162K | 0.03% | 551 |
|
|
2022
Q4 | $2.01M | Sell |
7,223
-2,064
| -22% | -$521K | 0.05% | 441 |
|
|
2022
Q3 | $1.94M | Buy |
9,287
+2,713
| +41% | +$607K | 0.05% | 441 |
|
|
2022
Q2 | $1.55M | Buy |
6,574
+3,256
| +98% | +$662K | 0.03% | 535 |
|
|
2022
Q1 | $595K | Sell |
3,318
-396
| -11% | -$75.4K | 0.01% | 937 |
|
|
2021
Q4 | $803K | Buy |
3,714
+184
| +5% | +$36.1K | 0.01% | 864 |
|
|
2021
Q3 | $652K | Buy |
3,530
+670
| +23% | +$132K | 0.01% | 908 |
|
|
2021
Q2 | $513K | Sell |
2,860
-214
| -7% | -$40.8K | 0.01% | 1020 |
|
|
2021
Q1 | $514K | Buy |
3,074
+392
| +15% | +$65.4K | 0.01% | 954 |
|
|
2020
Q4 | $407K | Sell |
2,682
-34
| -1% | -$4.46K | 0.01% | 972 |
|
|
2020
Q3 | $274K | Sell |
2,716
-2,582
| -49% | -$283K | 0.01% | 1023 |
|
|
2020
Q2 | $641K | Buy |
+5,298
| New | +$596K | 0.02% | 712 |
|
|
2020
Q1 | – | Sell |
-5,121
| Closed | -$451K | – | 1332 |
|
|
2019
Q4 | $451K | Hold |
5,121
| – | – | 0.01% | 878 |
|
|
2019
Q3 | $408K | Buy |
5,121
+1,267
| +33% | +$102K | 0.01% | 870 |
|
|
2019
Q2 | $301K | Buy |
+3,854
| New | +$360K | 0.01% | 1005 |
|
|
2018
Q1 | – | Sell |
-1,616
| Closed | -$239K | – | 1395 |
|
|
2017
Q4 | $239K | Buy |
+1,616
| New | +$205K | 0.01% | 1144 |
|
|
2015
Q3 | – | Sell |
-2,055
| Closed | -$357K | – | 1464 |
|
|
2015
Q2 | $357K | Buy |
+2,055
| New | +$370K | 0.01% | 1026 |
|
|
2014
Q3 | – | Sell |
-4,187
| Closed | -$371K | – | 1492 |
|
|
2014
Q2 | $371K | Buy |
+4,187
| New | +$403K | 0.01% | 970 |
|
|
2013
Q3 | – | Sell |
-27,960
| Closed | -$1.84M | – | 1368 |
|
|
2013
Q2 | $1.84M | Buy |
+27,960
| New | +$1.8M | 0.07% | 324 |
|
Other funds holding UTHR
Oppenheimer & Co's UTHR Position: Q3 2026 in Review
Oppenheimer & Co reduced its United Therapeutics (UTHR) stake by 2.5% in Q3 2026, selling an estimated $40.3K and leaving 3,012 shares worth $1.63M. The position accounts for 0.02% of the portfolio, ranked #707.
Oppenheimer & Co first reported a position in UTHR in Q2 2013 and has held it in 33 quarters since. The position peaked at $2.24M in Q3 2024. 241 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Oppenheimer & Co held 3,012 shares of United Therapeutics worth $1.63M as of Q3 2026.
- Oppenheimer & Co sold 78 United Therapeutics shares in Q3 2026, an estimated $40.3K.
- United Therapeutics made up 0.02% of Oppenheimer & Co's portfolio in Q3 2026, its #707 holding.
- Oppenheimer & Co first reported a position in United Therapeutics in Q2 2013 and has held it in 33 quarters since.
- Oppenheimer & Co's United Therapeutics position peaked at $2.24M in Q3 2024.
- 241 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Oppenheimer & Co's 13F filing for Q3 2026, filed 26 Oct 2026.